Terry Hyslop

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Gerandomiseerde ...

Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Gerandomiseerde Kl...

CALGB 40603: langetermijn en genomische correlaten van neoadjuvant bij mammacarcinoom